ArticleUrology case reports2022
Bladder tumour as a first manifestation of metastatic choroid melanoma.
Article in Urology case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Incidence of melanoma has been increasing, being able to metastasize to any organ with variable clinical presentation and evolution. We present the case of a patient with choroid melanoma metastasis to the bladder, managed by transurethral resection of the bladder with apparent full excision, additional investigation identified probable peritoneal and pulmonary metastases. Further exams revealed a stable pulmonary lesion and no peritoneal disease. Patient was proposed for surveillance. Treatment of metastatic melanoma is variable, some advocate metastasectomy for single metastasis, others systemic therapy or radiotherapy. Regardless of treatment options and new treatments the prognosis of metastatic disease is markedly unfavourable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.